• Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a highly collegial group that is dedicated to the pursuit of excellence and advancement of critical care research in Canada.
  • Canadian Critical Care Trials Group
    The CCCTG has are more than 30 research programs underway and over 100 peer-reviewed publications to its credit, with direct impact on clinical practice in critical care.
  • Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a national organization of more than 300 individuals with research interests in the management of the critically ill patient.
  • Canadian Critical Care Trials Group
    Endorsement by the CCCTG communicates our full commitment to ensure that the work is undertaken in a rigorous and ethical manner, and communicated in a timely and effective way.


The Hospital for Sick Children



Contact This Member

Jamie Hutchison

Jamie Hutchison has published over 50 peer reviewed manuscripts, delivered over 120 invited lectures and is Past-Chair of the Canadian Critical Care Translational Biology Group.

Dr. Jamie Hutchison is a Staff Physician, with a special focus on Neurocritical Care, and Director of Research in the Department of Critical Care at the Hospital for Sick Children (SickKids) in Toronto, Ontario, Canada. He is also a Professor of Pediatrics and Associate Scientist in the Institute for Medical Science at the University of Toronto and Senior Scientist in the Neuroscience and Mental Health Research Program at SickKids. His research focus is neuroprotection, and the discovery of biomarkers, in severe brain injuries and his laboratory is focused on mechanisms of neuroinflammation and cell death. He was the lead investigator in the largest multi-center randomized controlled trial of a potential neuroprotective (hypothermia) therapy in children with severe traumatic brain injury (TBI) published in the New England Journal of Medicine in 2008. Most recently Dr. Hutchison and his collaborators have discovered novel electrophysiologic, molecular and imaging biomarkers of prognosis in children with TBI. He is currently the principal investigator of “A National Biobank and Database for Patients with Traumatic Brain Injury (CanTBI)” funded by a Platform Support Grant from Brain Canada with funding partners from Vancouver to Halifax. He is Co-Chair (with Dr. Alexis Turgeon) of the Canadian Traumatic Brain Injury Research Consortium and past chair of the Canadian Critical Care Translational Biology Group both of which have core funding from the Canadian Institutes of Health Research and partners. Dr. Hutchison has trained and mentored many clinical and research trainees over the years many of whom have developed their own successful research programs.